Educational Activities Archives

Opioid overdose remains a national emergency, and EMS responders are often the first — and sometimes only — healthcare professionals to encounter patients at a critical moment. This SAEM podcast explores the emerging practice of EMS-initiated buprenorphine, an innovative approach that allows paramedics to begin medication for opioid use disorder in the field.

According to the Substance Abuse and Mental Health Services Administration, in 2019, only 10% of adults in the U.S with any substance use disorder (SUD) received treatment in part because effective evidence-based treatments for SUDs can be difficult to access in many communities.  CCBHCs help address this issue, delivering easily accessible and effective outpatient behavioral health care and SUD treatment through activities including expanded operating hours, same-day and walk-in appointments, outreach to sidelined populations and moving service delivery beyond clinic walls to reach people in their homes and in the community.

Over 2.5 million adults in the U.S. are diagnosed with OUD. In 2022, 12.7% of ED visits involved opioids. Yet only 25% of those who need treatment receive recommended MOUD. MOUDs are highly effective treatments that have been shown to decrease opioid use, cravings and transmission of infectious disease, and to increase retention in treatment. As the opioid epidemic continues to impact people across the U.S., the ED represents a critical access point to the health care system, supporting people with OUD by initiating MOUD, such as buprenorphine, and connecting them to low-threshold, easy-to-access care for continued treatment.

Emergency Department Bridge Programs allow ED physicians to connect patients in the ED with comprehensive addiction care. While the benefits of bridge programs for patients with opioid use disorder are known, what’s less understood is how these programs affect the lives of the providers themselves. For a paper published in Academic Emergency Medicine last year, researchers interviewed providers about these programs and found that patients were not the only benefactors.

Participants who engage in this activity will understand opioid pharmacology and evidence on benefits and harms of opioid therapy for chronic pain. Additionally, participants learn risk factors for opioid overdose and OUD, risk assessment of patients for long-term opioid therapy, methods for mitigating risks of opioid therapy, and approaches for discontinuing or tapering opioids.

In this module participants review how to identify the main principles of pain treatment in opioid use disorder and to describe how these principles are applied to the treatment of acute pain as well as chronic non-terminal, non-cancer pain in OUD. Specifically, participants will learn to manage opioid withdrawal and acute pain in patients with OUD during hospitalization with and without receiving concomitant MOUD. Participants will examine strategies in formulating a multimodal pain plan for chronic pain in patients with OUD.